- ►nih.gov [PDF] JR Condon, SBM Reith, JR Nassim, FJC … - British Medical …, 1971 - pubmedcentral.nih.gov Summary We report data from three patients with severe Pagetes disease of bone who were treated with
mithramycin. Mithramycin infusion resulted in a fail in plasma cal, phosphate, akaline phosphatase,
and uninary hydroxyoline excretion. ... Cited by 29 - Related articles - All 5 versions
WG Ryan, TB Schwartz, G Northrop - JAMA, 1970 - Am Med Assoc The effects of mithramycin, an antibiotic with cytotoxic activity, were observed in 15 patients with
active Paget's disease of bone. Mithramycin is shown to have a consistent effect in suppressing the
activity of Paget's disease, as ... Cited by 22 - Related articles - All 2 versions
- ►ejbjs.org [PDF] EG Elias, JT EVANS - The Journal of Bone and Joint Surgery, 1972 - JBJS Page 1. The PDF of the article you requested follows this cover page. This is an enhanced PDF
from The Journal of Bone and Joint Surgery 1972;54:1730-1736. J Bone Joint Surg Am. EG ELIAS
and JAMES T. EVANS Mithramycin in the Treatment of Paget's Disease of Bone ... Cited by 20 - Related articles - All 2 versions
- ►nih.gov [PDF] V Parsons, M Baum, M Self - British Medical Journal, 1967 - pubmedcentral.nih.gov REFERENCES Ball, G., Rojas, J A., and Dyer, I. (1961). Obstet. and Gynec., 18, 609. Campbell, R. M.
(1962). Amer. 7. Obstet. Gynec., 83, 1447. Cope, E. (1951). 7. Obstet. Gynaec. Brit. Emp., 58, 259.
Cox, L. W. (1951). Lancet, 1, 561. ... Cited by 54 - Related articles - All 3 versions
WG Ryan, TB Schwartz, G Northrop - Seminars in drug treatment, 1972 - ncbi.nlm.nih.gov 1: Semin Drug Treat. 1972 Summer;2(1):57-64. Treatment of Paget's disease with mithramycin:
further experiences. Ryan WG, Schwartz TB, Northrop G. Mesh Terms: Alkaline
Phosphatase/blood; Antibiotics, Antineoplastic/therapeutic use*; Gluconates ... Cited by 11 - Related articles
D LEBBIN, WG RYAN, TB SCHWARTZ - Annals of Internal Medicine, 1974 - Am Coll Physicians Mithramycin is a cytotoxic antibiotic that causes hypocalcemia and diminishes the elevated
osteoclastic activity characteristic of Paget's disease. Previous inpatient studies have shown that
this drug causes striking clinical ... Cited by 16 - Related articles - All 3 versions
- ►nih.gov [PDF] AS Russell, BC Lentle - Canadian Medical Association Journal, 1974 - pubmedcentral.nih.gov Summary: Nine patients with symptomatic Paget's disease were treated with mithramycin in doses of 15
yug/kg/day for 10 days. All but one had considerable symptomatic improvement and, in some, pain
relief was dramatic after only a ... Cited by 9 - Related articles - All 4 versions
- ►nih.gov [PDF] JJ Fennelly, JF Groarke - British Medical Journal, 1971 - pubmedcentral.nih.gov References Albright, F., and Henneman, PH (1955). Transactions of the Association of American
Physicians, 68, 238. Albright, F., and Reifenstein, EC (1948). The Parathyroid Glands and Metabolic
Bone Disease, p. 284. Baltimore, ... Cited by 14 - Related articles - All 4 versions
JG Haddad Jr, SJ Birge, LV Avioli - The New England journal of …, 1970 - ncbi.nlm.nih.gov 1: N Engl J Med. 1970 Sep 10;283(11):549-55. Effects of prolonged thyrocalcitonin
administration on Paget's disease of bone. Haddad JG Jr, Birge SJ, Avioli LV. Mesh Terms:
Administration, Oral; Alkaline Phosphatase/blood; Bone and Bones/metabolism; ... Cited by 42 - Related articles
